The kinase TBK1 participates in signaling pathways that induce antimicrobial responses. TBK1 is also necessary for the suppression of excessive production of immunoglobulin A by accelerating destruction of the kinase NIK.
References
Jin, J. et al. Nat. Immunol. 13, 1101–1109 (2012).
Macpherson, A.J., Geuking, M.B. & McCoy, K.D. Trends Immunol. 33, 160–167 (2012).
Mora, J.R. & von Andrian, U.H. Mucosal Immunol. 1, 96–109 (2008).
Wang, N. et al. Mol. Med. 17, 1383–1396 (2011).
Chorny, A., Puga, I. & Cerutti, A. Adv. Immunol. 107, 31–69 (2010).
Thu, Y.M. & Richmond, A. Cytokine Growth Factor Rev. 21, 213–226 (2010).
Sanjo, H., Zajonc, D.M., Braden, R., Norris, P.S. & Ware, C.F. J. Biol. Chem. 285, 17148–17155 (2010).
Häcker, H. & Karin, M. Sci. STKE 2006, re13 (2006).
Wolf, A.I. et al. J. Clin. Invest. 121, 3954–3964 (2011).
Shen, R.R. & Hahn, W.C. Oncogene 30, 631–641 (2011).
Pilli, M. et al. Immunity 37, 223–234 (2012).
Marchlik, E. et al. J. Leukoc. Biol. 88, 1171–1180 (2010).
Herman, M. et al. J. Exp. Med. 209, 1567–1582 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
R.J.B. is listed as a coinventor on patents related to the gene encoding TACI.
Rights and permissions
About this article
Cite this article
Bram, R. TBK1 suppression of IgA in the NIK of time. Nat Immunol 13, 1027–1029 (2012). https://doi.org/10.1038/ni.2451
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.2451
- Springer Nature America, Inc.
This article is cited by
-
Interplay between ADP-ribosyltransferases and essential cell signaling pathways controls cellular responses
Cell Discovery (2021)
-
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study
Signal Transduction and Targeted Therapy (2020)